1. Home
  2. CGEM vs DGICB Comparison

CGEM vs DGICB Comparison

Compare CGEM & DGICB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cullinan Oncology Inc.

CGEM

Cullinan Oncology Inc.

HOLD

Current Price

$11.84

Market Cap

671.7M

Sector

Health Care

ML Signal

HOLD

DGICB

Donegal Group Inc. Class B

HOLD

Current Price

$15.58

Market Cap

562.0M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
CGEM
DGICB
Founded
2016
1986
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Property-Casualty Insurers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
671.7M
562.0M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
CGEM
DGICB
Price
$11.84
$15.58
Analyst Decision
Strong Buy
Analyst Count
8
0
Target Price
$28.13
N/A
AVG Volume (30 Days)
707.4K
2.1K
Earning Date
02-26-2026
02-19-2026
Dividend Yield
N/A
4.24%
EPS Growth
N/A
219.91
EPS
N/A
2.38
Revenue
N/A
$987,826,105.00
Revenue This Year
N/A
$2.26
Revenue Next Year
N/A
$3.46
P/E Ratio
N/A
$8.06
Revenue Growth
N/A
0.89
52 Week Low
$5.68
$13.19
52 Week High
$13.33
$20.46

Technical Indicators

Market Signals
Indicator
CGEM
DGICB
Relative Strength Index (RSI) 57.77 42.25
Support Level $11.53 $15.26
Resistance Level $12.99 $16.43
Average True Range (ATR) 0.76 0.36
MACD 0.12 -0.25
Stochastic Oscillator 61.36 12.21

Price Performance

Historical Comparison
CGEM
DGICB

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.

About DGICB Donegal Group Inc. Class B

Donegal Group Inc is an insurance holding company that offers businesses and individuals personal and commercial lines of property and casualty insurance. The company's reportable segments are its Investment function, Personal lines of insurance, and Commercial lines of insurance. Personal lines products consist mainly of homeowners and private passenger automobile policies. The Commercial lines products of its insurance subsidiaries consist mainly of commercial automobile, commercial multi-peril, and workers' compensation policies. The group mainly operates in the United States.

Share on Social Networks: